135 related articles for article (PubMed ID: 4362033)
1. Chemotherapy of breast cancer. Investigational treatment.
Jones SE
Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
[No Abstract] [Full Text] [Related]
2. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
Ward HW
Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
[No Abstract] [Full Text] [Related]
3. [Clinical effect of Peplomycin on recurrent breast cancer].
Kimura M; Koida T; Fukuda T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1665-9. PubMed ID: 6191688
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
Wang ZY
Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
Hansen M; Palshof T; Osterlind K; Hansen HH; Mouridsen H
Cancer Treat Rep; 1977 Nov; 61(8):1603-5. PubMed ID: 922762
[No Abstract] [Full Text] [Related]
6. Solid tumor chemotherapy: new drugs and horizons.
Yardumian H
J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203
[No Abstract] [Full Text] [Related]
7. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
8. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
Einhorn LH; Livingston RB; Gottlieb JA
Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
[No Abstract] [Full Text] [Related]
10. Adriamycin and CCNU in the treatment of advanced breast cancer.
Muss HB; White DR; Richards F; Cooper MR; Spurr CL
Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240
[No Abstract] [Full Text] [Related]
11. Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases.
Khandekar JD; Victor TA; Mukhopadhyaya P
Arch Intern Med; 1978 Apr; 138(4):539-41. PubMed ID: 205183
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, prednisone, staphage lysate and warfarin in disseminated breast cancer.
D'Souza DP; Daly L; Thornes RD
Ir Med J; 1980 Oct; 73(10):385-7. PubMed ID: 7429789
[No Abstract] [Full Text] [Related]
13. Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.
Ibrahim NK; Frye DK; Buzdar AU; Walters RS; Hortobagyi GN
Arch Intern Med; 1996 Apr; 156(8):882-8. PubMed ID: 8774207
[TBL] [Abstract][Full Text] [Related]
14. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
Minisini AM; Andreetta C; Fasola G; Puglisi F
Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
[TBL] [Abstract][Full Text] [Related]
15. Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
Cossaart N; SantaCruz KS; Preston D; Johnson P; Skikne BS
Bone Marrow Transplant; 2003 Jan; 31(1):57-60. PubMed ID: 12621508
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Booser DJ; Esteva FJ; Rivera E; Valero V; Esparza-Guerra L; Priebe W; Hortobagyi GN
Cancer Chemother Pharmacol; 2002 Jul; 50(1):6-8. PubMed ID: 12111105
[TBL] [Abstract][Full Text] [Related]
17. [New 2004 guidelines of the Breast Organ Committee of AGO].
Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
[No Abstract] [Full Text] [Related]
18. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
Band PR; Canellos GP; Sears M; Israel L; Pocock SJ
Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416
[No Abstract] [Full Text] [Related]
19. Bisantrene, an active new drug in the treatment of metastatic breast cancer.
Yap HY; Yap BS; Blumenschein GR; Barnes BC; Schell FC; Bodey GP
Cancer Res; 1983 Mar; 43(3):1402-4. PubMed ID: 6825109
[TBL] [Abstract][Full Text] [Related]
20. Primary breast cancer: some considerations concerning its management.
Fisher B
Surg Annu; 1971; 3(0):227-48. PubMed ID: 4367373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
